Gene, Cell and Tissue

Published by: Kowsar

Lack of Association Between Superoxide Dismutase Gene Polymorphism and Malignant Lymphoproliferative Disorders

Alireza Nakhaee 1 , 2 , Mohammad Ali Mashhadi 3 , 4 , * , Mohaddeseh Zademir 5 , Zahra Sepehri 6 and Derek Kennedy 7
Authors Information
1 Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
2 Department of Clinical Biochemistry, Zahedan University of Medical Sciences, Zahedan, IR Iran
3 Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
4 Department of Internal Medicine, Zahedan University of medical Sciences, Zahedan, IR Iran
5 Department of Radiology, Zahedan University of Medical Sciences, Zahedan, IR Iran
6 Department of Internal Medicine, Zabol University of Medical Sciences, Zabol, IR Iran
7 School of Natural Sciences and Eskitis Institute for Drug Discovery, Griffith University, Brisbane, Australia
Article information
  • Gene, Cell and Tissue: July 01, 2016, 3 (3); e37768
  • Published Online: May 11, 2016
  • Article Type: Research Article
  • Received: March 13, 2016
  • Revised: April 22, 2016
  • Accepted: April 23, 2016
  • DOI: 10.17795/gct-37768

To Cite: Nakhaee A, Mashhadi M A, Zademir M, Sepehri Z, Kennedy D. Lack of Association Between Superoxide Dismutase Gene Polymorphism and Malignant Lymphoproliferative Disorders, Gene Cell Tissue. 2016 ; 3(3):e37768. doi: 10.17795/gct-37768.

Abstract
Copyright © 2016, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Subramaniam K, D'Rozario J, Pavli P. Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review. J Gastroenterol Hepatol. 2013; 28(1): 24-30[DOI][PubMed]
  • 2. Garon JE. Principles of clinical laboratory utilization and consultation. Arch Pathol Lab Med. 2000; 124(4): 644[PubMed]
  • 3. Carbone A, Gloghini A, Dotti G. EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist. 2008; 13(5): 577-85[DOI][PubMed]
  • 4. Kristinsson SY, Koshiol J, Goldin LR, Bjorkholm M, Turesson I, Gridley G, et al. Genetics- and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/ Waldenstrom's macroglobulinemia. Clin Lymphoma Myeloma. 2009; 9(1): 23-6[DOI][PubMed]
  • 5. Tanner SM, Austin JL, Leone G, Rush LJ, Plass C, Heinonen K, et al. BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proc Natl Acad Sci U S A. 2001; 98(24): 13901-6[DOI][PubMed]
  • 6. Halliwell B. Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis. Br J Exp Pathol. 1989; 70(6): 737-57[PubMed]
  • 7. Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India. 2004; 52: 794-804[PubMed]
  • 8. Deavall DG, Martin EA, Horner JM, Roberts R. Drug-induced oxidative stress and toxicity. J Toxicol. 2012; 2012: 645460[DOI][PubMed]
  • 9. Hancock JT, Desikan R, Neill SJ. Role of reactive oxygen species in cell signalling pathways. Biochem Soc Trans. 2001; 29: 345-50[PubMed]
  • 10. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003; 17(10): 1195-214[DOI][PubMed]
  • 11. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A. 1988; 85(24): 9748-52[PubMed]
  • 12. Battisti V, Maders LD, Bagatini MD, Santos KF, Spanevello RM, Maldonado PA, et al. Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients. Clin Biochem. 2008; 41(7-8): 511-8[DOI][PubMed]
  • 13. Phoonlapdacha P, Chongviriyaphan N, Pakakasama S, Kalpravidh RW, Suthutvoravut U. Antioxidant status and lipid peroxidation in pediatric patients with acute lymphoblastic leukemia. FASEB Journal. 2008; 22(1_MeetingAbstracts): 890.9
  • 14. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med. 2002; 33(3): 337-49[PubMed]
  • 15. Church SL, Grant JW, Meese EU, Trent JM. Sublocalization of the gene encoding manganese superoxide dismutase (MnSOD/SOD2) to 6q25 by fluorescence in situ hybridization and somatic cell hybrid mapping. Genomics. 1992; 14(3): 823-5[PubMed]
  • 16. Yuzhalin AE, Kutikhin AG. Inherited variations in the SOD and GPX gene families and cancer risk. Free Radic Res. 2012; 46(5): 581-99[DOI][PubMed]
  • 17. Borgstahl GE, Parge HE, Hickey MJ, Johnson MJ, Boissinot M, Hallewell RA, et al. Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface. Biochemistry. 1996; 35(14): 4287-97[DOI][PubMed]
  • 18. Sutton A, Khoury H, Prip-Buus C, Cepanec C, Pessayre D, Degoul F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenet Genomics. 2003; 13(3): 145-57
  • 19. Yi JF, Li YM, Liu T, He WT, Li X, Zhou WC, et al. Mn-SOD and CuZn-SOD polymorphisms and interactions with risk factors in gastric cancer. World J Gastroenterol. 2010; 16(37): 4738-46[PubMed]
  • 20. Mitrunen K, Sillanpaa P, Kataja V, Eskelinen M, Kosma VM, Benhamou S, et al. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis. 2001; 22(5): 827-9[PubMed]
  • 21. Mao C, Qiu LX, Zhan P, Xue K, Ding H, Du FB, et al. MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 subjects. J Cancer Res Clin Oncol. 2010; 136(7): 975-9[DOI][PubMed]
  • 22. Arsova-Sarafinovska Z, Matevska N, Petrovski D, Banev S, Dzikova S, Georgiev V, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer. Cell Biochem Funct. 2008; 26(7): 771-7[DOI][PubMed]
  • 23. Rosenblum JS, Gilula NB, Lerner RA. On signal sequence polymorphisms and diseases of distribution. Proc Natl Acad Sci U S A. 1996; 93(9): 4471-3[PubMed]
  • 24. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun. 1996; 226(2): 561-5[DOI][PubMed]
  • 25. Ambrosone CB, Freudenheim JL, Thompson PA, Bowman E, Vena JE, Marshall JR, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res. 1999; 59(3): 602-6[PubMed]
  • 26. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell. 2005; 120(4): 483-95[DOI][PubMed]
  • 27. Lightfoot TJ, Skibola CF, Smith AG, Forrest MS, Adamson PJ, Morgan GJ, et al. Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma. Haematologica. 2006; 91(9): 1222-7[PubMed]
  • 28. Woodson K, Tangrea JA, Lehman TA, Modali R, Taylor KM, Snyder K, et al. Manganese superoxide dismutase (MnSOD) polymorphism, α-tocopherol supplementation and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (Finland). Cancer Causes Control. 2003; 14(6): 513-8
  • 29. Blein S, Berndt S, Joshi AD, Campa D, Ziegler RG, Riboli E, et al. Factors associated with oxidative stress and cancer risk in the Breast and Prostate Cancer Cohort Consortium. Free Radic Res. 2014; 48(3): 380-6[DOI][PubMed]
  • 30. Cai Q, Shu XO, Wen W, Cheng JR, Dai Q, Gao YT, et al. Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Breast Cancer Res. 2004; 6(6)-55[DOI][PubMed]
  • 31. Xu Z, Zhu H, Luk JM, Wu D, Gu D, Gong W, et al. Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer. Cancer. 2012; 118(22): 5489-96[DOI][PubMed]
  • 32. Cengiz M, Ozaydin A, Ozkilic AC, Dedekarginoglu G. The investigation of GSTT1, GSTM1 and SOD polymorphism in bladder cancer patients. Int Urol Nephrol. 2007; 39(4): 1043-8[DOI][PubMed]
  • 33. Crawford A, Fassett RG, Geraghty DP, Kunde DA, Ball MJ, Robertson IK, et al. Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene. 2012; 501(2): 89-103[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments